Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
ObjectiveThis study aimed to investigate the association between nutritional appetite status-assessed during a standardized eight-week hospitalization period using the Simplified Nutritional Appetite Questionnaire (SNAQ)-and discharge outcomes at a one-year follow-up in older hospitalized patients with multiple comorbidities.MethodsA prospective one-year observational study was conducted in a convalescent geriatric hospital. This study was conducted with 77 patients aged 65 and older with comorbidities who have been on oral intake for more than 8 weeks after hospitalization. Patients were divided into low ( = 40) and normal ( = 37) appetite groups based on a SNAQ score cut-off of 14. Odds ratio (OR) analysis was conducted to compare improved and deteriorated discharge outcomes at the one-year mark according to appetite status, adjusted for Charlson comorbidity index, activities of daily living score, and nutritional intake.ResultsThe low appetite group had significantly lower energy (1215.68 ± 68.96 kcal vs. 1495.50 ± 48.03 kcal, = 0.001) and protein intake (55.66 ± 2.83 g vs. 65.75 ± 1.88 g, = 0.004). They reported poorer appetite, felt full with fewer mouthfuls, worse food taste, and fewer meals daily ( < 0.05). Adjusted for Charlson comorbidity index, Activities of daily living score, and nutritional intake, the low appetite group had a higher risk of adverse discharge outcomes, such as death or intensive care, with an adjusted OR of 8.524 (95% CI: 1.331-59.739, = 0.024). Their likelihood of improvement, defined as discharge to a nursing home or home, was reduced, with an adjusted OR of 0.109 (95% CI: 0.013-0.915, = 0.041).ConclusionsThis study underscores the clinical importance of assessing and promoting appetite to improve discharge outcomes and reduce healthcare costs for long-term hospitalized geriatric patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12319209 | PMC |
| http://dx.doi.org/10.1177/00368504251364949 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Strong Families Start at Home/Familias Fuertes Comienzan en Casa-Improving Child Diet Quality and Parental Feeding Practices: Protocol for a Randomized Controlled Trial.
JMIR Res Protoc
September 2025
Institute for Collaboration on Health, Intervention, and Policy, University of Connecticut, Storrs, CT, United States.
Background: Children in the United States have poor diet quality, increasing their risk for chronic disease burden later in life. Caregivers' feeding behaviors are a critical factor in shaping lifelong dietary habits. The Strong Families Start at Home/Familias Fuertes Comienzan en Casa (SFSH) was a 6-month, home-based, pilot randomized-controlled feasibility trial that aimed to improve the diet quality of 2-5-year-old children and promote positive parental feeding practices among a predominantly Hispanic/Latine sample.
View Article and Find Full Text PDFAssociated factors for exertional heat exhaustion-related symptoms among amateur golfers in Japan: A retrospective case-control study.
Temperature (Austin)
June 2025
Kanto Golf Association, Chuo-ku, Tokyo, Japan.
The associated factors for exertional heat stroke among amateur golfers remain poorly understood. We conducted a case-control study to examine exertional heat exhaustion (EHE) - related symptoms among amateur golfers in Japan using a self-administered questionnaire. Retrospective case-control study design.
View Article and Find Full Text PDFReal-world experience with the use of diazoxide among people living with congenital hyperinsulinism and their caregivers.
Front Endocrinol (Lausanne)
September 2025
Congenital Hyperinsulinism International, Glen Ridge, NJ, United States.
Introduction: Congenital hyperinsulinism (HI) is a rare disease that causes severe hypoglycemia. Diazoxide is the first-line treatment; however, many individuals using diazoxide continue to experience hypoglycemia. Diazoxide is associated with side effects that impact life and well-being.
View Article and Find Full Text PDFAppetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study.
Diabetes Obes Metab
September 2025
Eli Lilly and Company, Indianapolis, Indiana, USA.
Aims: To determine whether adults with type 2 diabetes (T2D) treated with retatrutide report greater changes in self-reported appetite, dietary restraint, and disinhibition compared to placebo or dulaglutide and to examine associations with weight change.
Materials And Methods: These pre-specified exploratory analyses examined changes from baseline in Appetite Visual Analogue Scale (VAS) and Eating Inventory (EI) scores after 24 and 36 weeks of once-weekly treatment with placebo, dulaglutide 1.5 mg, or retatrutide 0.
Microbiota-Dependent Fiber Responses: A Proof-of-Concept Study on Short-chain Fatty Acid Production in Prevotella- and Bacteroides-Dominated Healthy Individuals.
J Nutr
September 2025
Institute of Food and One Health, Leibniz University Hannover, 30167 Hannover, Germany.
Background: Dietary fiber supports metabolic health via microbial fermentation, producing short-chain fatty acids (SCFAs). However, metabolic responses to fiber vary between individuals, potentially due to differences in gut microbiota composition. The Prevotella-to-Bacteroides (P/B) ratio has emerged as a potential biomarker for fiber responsiveness.
View Article and Find Full Text PDF